These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25955017)

  • 1. The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer.
    Yamamoto N; Nishikawa R; Chiyomaru T; Goto Y; Fukumoto I; Usui H; Mitsuhashi A; Enokida H; Nakagawa M; Shozu M; Seki N
    Int J Oncol; 2015 Jul; 47(1):325-34. PubMed ID: 25955017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C.
    Mataki H; Enokida H; Chiyomaru T; Mizuno K; Matsushita R; Goto Y; Nishikawa R; Higashimoto I; Samukawa T; Nakagawa M; Inoue H; Seki N
    J Hum Genet; 2015 Feb; 60(2):53-61. PubMed ID: 25518741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
    Yamasaki T; Yoshino H; Enokida H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Fuse M; Seki N; Nakagawa M
    Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.
    Nohata N; Hanazawa T; Kikkawa N; Sakurai D; Sasaki K; Chiyomaru T; Kawakami K; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2011 Nov; 39(5):1099-107. PubMed ID: 21701775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
    Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
    J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
    Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
    J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
    Nishikawa R; Goto Y; Kurozumi A; Matsushita R; Enokida H; Kojima S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    Int J Urol; 2015 Sep; 22(9):867-77. PubMed ID: 26059417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
    Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
    Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.
    Kato M; Goto Y; Matsushita R; Kurozumi A; Fukumoto I; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
    Int J Oncol; 2015 Aug; 47(2):710-8. PubMed ID: 26063484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
    Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.
    Mizuno K; Seki N; Mataki H; Matsushita R; Kamikawaji K; Kumamoto T; Takagi K; Goto Y; Nishikawa R; Kato M; Enokida H; Nakagawa M; Inoue H
    Int J Oncol; 2016 Feb; 48(2):450-60. PubMed ID: 26676674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
    Kojima S; Enokida H; Yoshino H; Itesako T; Chiyomaru T; Kinoshita T; Fuse M; Nishikawa R; Goto Y; Naya Y; Nakagawa M; Seki N
    J Hum Genet; 2014 Feb; 59(2):78-87. PubMed ID: 24284362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.
    Chung TK; Lau TS; Cheung TH; Yim SF; Lo KW; Siu NS; Chan LK; Yu MY; Kwong J; Doran G; Barroilhet LM; Ng AS; Wong RR; Wang VW; Mok SC; Smith DI; Berkowitz RS; Wong YF
    Int J Cancer; 2012 Mar; 130(5):1036-45. PubMed ID: 21400511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Zhu D; Sun Y; Zhang D; Dong M; Jiang G; Zhang X; Zhou J
    Oncol Rep; 2018 Aug; 40(2):589-598. PubMed ID: 29845255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.
    Qiu T; Zhou X; Wang J; Du Y; Xu J; Huang Z; Zhu W; Shu Y; Liu P
    FEBS Lett; 2014 Apr; 588(7):1168-77. PubMed ID: 24613927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.